• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

外周淋巴结中 CD4+CD25+Foxp3+细胞和功能强大的 CD103+亚群的频率降低与某些品系小鼠的自身免疫性疾病易感性相关。

Decreased frequencies of CD4+CD25+Foxp3+ cells and the potent CD103+ subset in peripheral lymph nodes correlate with autoimmune disease predisposition in some strains of mice.

机构信息

Department of Microbiology and Immunology, University of Louisville, Louisville, KY 40292, USA.

出版信息

Autoimmunity. 2011 Sep;44(6):453-64. doi: 10.3109/08916934.2011.568553. Epub 2011 May 23.

DOI:10.3109/08916934.2011.568553
PMID:21604973
Abstract

The CD4(+)CD25(+)Foxp3(+) cells are essential for regulation of the immune response, and the integrin, CD103 (α(E)β(7)), identifies a potent subset of these cells. Defects in CD4(+)CD25(+)Foxp3(+) cells are thought to contribute to susceptibility to autoimmune disease in predisposed individuals. Studies evaluating the quality and quantity of CD4(+)CD25(+)Foxp3(+) regulatory cell populations in the context of autoimmune disease susceptibility have been inconclusive, and few if any, have analyzed the CD103 subset. In this study, we analyzed regulatory T cells (Tregs) from different strains of mice with varying degrees of susceptibility to autoimmune disease. We found no differences in the ability of CD4(+)CD25(+) or the CD103(+) subset of Tregs from young female (NZB × NZW)F1 (BWF1), SJL, C57BL/6, or BALB/c mice to suppress CD4(+)CD25(- ) responders in vitro. Analysis of CD4(+)Foxp3(+) and CD4(+)CD25(+)CD103(+) cell frequencies in lymphoid organs revealed that BWF1 mice had dramatically lower percentages of both populations in the lymph node (LN) than the other strains, and lower percentages in the spleen in all but the C57BL/6 strain. We next determined whether these findings extended to another autoimmune-prone strain. Similar to BWF1 mice, percentages of CD4(+)Foxp3(+) and CD4(+)CD25(+)CD103(+) cells were significantly lower in predisease NOD mice. The low frequencies of CD4(+)Foxp3(+) and CD4(+)CD25(+)CD103(+) cells in BWF1 and NOD mice were not due to deficiencies in either thymic production or homeostatic proliferation. These data indicate that decreased percentages of CD4(+)Foxp3(+) cells and particularly, CD4(+)CD25(+)CD103(+) cells in LN correlate with the predisposition to spontaneous development of autoimmune disease.

摘要

CD4(+)CD25(+)Foxp3(+) 细胞对于免疫反应的调节至关重要,整合素 CD103(α(E)β(7))可以识别这些细胞的一个有效亚群。在易患自身免疫疾病的个体中,CD4(+)CD25(+)Foxp3(+)细胞的缺陷被认为是导致易感性的原因之一。然而,评估自身免疫疾病易感性背景下 CD4(+)CD25(+)Foxp3(+)调节性细胞群体的质量和数量的研究尚无定论,且很少有研究分析 CD103 亚群。在这项研究中,我们分析了不同自身免疫疾病易感性程度的不同品系小鼠中的调节性 T 细胞 (Treg)。我们发现,来自年轻雌性 (NZB × NZW)F1 (BWF1)、SJL、C57BL/6 或 BALB/c 小鼠的 CD4(+)CD25(+)或 CD103(+)Treg 亚群在体外抑制 CD4(+)CD25(-)应答的能力没有差异。对淋巴结 (LN)和脾脏中 CD4(+)Foxp3(+)和 CD4(+)CD25(+)CD103(+)细胞频率的分析表明,与其他品系相比,BWF1 小鼠的 LN 中这两个群体的百分比显著降低,除 C57BL/6 品系外,脾脏中的百分比也降低。我们接下来确定这些发现是否扩展到另一种自身免疫倾向的品系。与 BWF1 小鼠相似,疾病前 NOD 小鼠的 CD4(+)Foxp3(+)和 CD4(+)CD25(+)CD103(+)细胞的百分比也显著降低。BWF1 和 NOD 小鼠中 CD4(+)Foxp3(+)和 CD4(+)CD25(+)CD103(+)细胞的低频率不是由于胸腺产生或稳态增殖的缺陷所致。这些数据表明,LN 中 CD4(+)Foxp3(+)细胞和特别是 CD4(+)CD25(+)CD103(+)细胞的百分比降低与自发性自身免疫疾病发展的易感性相关。

相似文献

1
Decreased frequencies of CD4+CD25+Foxp3+ cells and the potent CD103+ subset in peripheral lymph nodes correlate with autoimmune disease predisposition in some strains of mice.外周淋巴结中 CD4+CD25+Foxp3+细胞和功能强大的 CD103+亚群的频率降低与某些品系小鼠的自身免疫性疾病易感性相关。
Autoimmunity. 2011 Sep;44(6):453-64. doi: 10.3109/08916934.2011.568553. Epub 2011 May 23.
2
Control of Schistosoma mansoni egg-induced inflammation by IL-4-responsive CD4(+)CD25(-)CD103(+)Foxp3(-) cells is IL-10-dependent.IL-4 反应性 CD4(+)CD25(-)CD103(+)Foxp3(-) 细胞通过 IL-10 依赖性途径控制曼氏血吸虫卵诱导的炎症。
Eur J Immunol. 2010 Oct;40(10):2837-47. doi: 10.1002/eji.200940075.
3
Changes of CD4+CD25+Foxp3+ regulatory T cells in aged Balb/c mice.老年Balb/c小鼠中CD4+CD25+Foxp3+调节性T细胞的变化
J Leukoc Biol. 2007 Jun;81(6):1386-94. doi: 10.1189/jlb.0506364. Epub 2007 Mar 16.
4
CD4+CD25+Foxp3+ regulatory T cells are dispensable for controlling CD8+ T cell-mediated lung inflammation.CD4+CD25+Foxp3+ 调节性 T 细胞对于控制 CD8+T 细胞介导的肺部炎症是可有可无的。
J Immunol. 2011 Jun 1;186(11):6106-18. doi: 10.4049/jimmunol.1000632. Epub 2011 Apr 25.
5
Expression of CD103 identifies human regulatory T-cell subsets.CD103的表达可识别人类调节性T细胞亚群。
J Allergy Clin Immunol. 2006 Dec;118(6):1342-9. doi: 10.1016/j.jaci.2006.07.034. Epub 2006 Sep 18.
6
Pancreatic islets induce CD4(+) [corrected] CD25(-)Foxp3(+) [corrected] T-cell regulated tolerance to HY-mismatched skin grafts.胰岛诱导CD4(+) [校正后] CD25(-)Foxp3(+) [校正后] T细胞对HY错配皮肤移植物产生调节性耐受。
Transplantation. 2008 Nov 27;86(10):1352-60. doi: 10.1097/TP.0b013e31818aa43c.
7
Increased CD4+CD25+Foxp3+ regulatory T cells in tolerance induced by portal venous injection.门静脉注射诱导的耐受中CD4+CD25+Foxp3+调节性T细胞增加。
Surgery. 2009 Jun;145(6):663-74. doi: 10.1016/j.surg.2009.01.016. Epub 2009 Apr 19.
8
CD4+Foxp3+ regulatory T cells converted by rapamycin from peripheral CD4+CD25(-) naive T cells display more potent regulatory ability in vitro.雷帕霉素将外周血 CD4+CD25(-) 初始 T 细胞体外诱导为 CD4+Foxp3+ 调节性 T 细胞后其体外调节能力增强。
Chin Med J (Engl). 2010 Apr 5;123(7):942-8.
9
Induction of CD4(+)CD25(+) T regulatory cells with CD103 depletion.诱导 CD4(+)CD25(+)T 调节细胞并耗尽 CD103。
J Surg Res. 2010 Sep;163(1):162-8. doi: 10.1016/j.jss.2010.04.021. Epub 2010 May 11.
10
Upregulating CD4+CD25+FOXP3+ regulatory T cells in pancreatic lymph nodes in diabetic NOD mice by adjuvant immunotherapy.通过辅助免疫疗法上调糖尿病NOD小鼠胰腺淋巴结中的CD4+CD25+FOXP3+调节性T细胞。
Transplantation. 2009 Jan 27;87(2):198-206. doi: 10.1097/TP.0b013e3181933261.

引用本文的文献

1
T Regulatory Cells From Non-obese Diabetic Mice Show Low Responsiveness to IL-2 Stimulation and Exhibit Differential Expression of Anergy-Related and Ubiquitination Factors.非肥胖型糖尿病小鼠中的调节性 T 细胞对 IL-2 刺激的反应性较低,并表现出与失能相关和泛素化因子的差异表达。
Front Immunol. 2019 Nov 25;10:2665. doi: 10.3389/fimmu.2019.02665. eCollection 2019.
2
Mouse-Derived Isograft (MDI) In Vivo Tumor Models I. Spontaneous sMDI Models: Characterization and Cancer Therapeutic Approaches.小鼠源同基因移植(MDI)体内肿瘤模型 I. 自发性sMDI模型:特征与癌症治疗方法
Cancers (Basel). 2019 Feb 19;11(2):244. doi: 10.3390/cancers11020244.
3
Mouse-Derived Isograft (MDI) In Vivo Tumor Models II. Carcinogen-Induced cMDI Models: Characterization and Cancer Therapeutic Approaches.
小鼠源同基因移植(MDI)体内肿瘤模型II. 致癌物诱导的cMDI模型:特征与癌症治疗方法
Cancers (Basel). 2019 Feb 19;11(2):242. doi: 10.3390/cancers11020242.
4
NKG2DCD4 T Cells Kill Regulatory T Cells in a NKG2D-NKG2D Ligand- Dependent Manner in Systemic Lupus Erythematosus.NKG2DCD4 T 细胞以 NKG2D-NKG2D 配体依赖的方式杀伤系统性红斑狼疮中的调节性 T 细胞。
Sci Rep. 2017 Apr 28;7(1):1288. doi: 10.1038/s41598-017-01379-y.
5
Regulatory T cells control strain specific resistance to Experimental Autoimmune Prostatitis.调节性 T 细胞控制实验性自身免疫性前列腺炎的菌株特异性抗性。
Sci Rep. 2016 Sep 14;6:33097. doi: 10.1038/srep33097.
6
Mechanisms of autoimmunity in the non-obese diabetic mouse: effector/regulatory cell equilibrium during peak inflammation.非肥胖糖尿病小鼠自身免疫的机制:炎症高峰期效应细胞/调节细胞平衡
Immunology. 2016 Apr;147(4):377-88. doi: 10.1111/imm.12581. Epub 2016 Feb 8.
7
Gut immune deficits in LEW.1AR1-iddm rats partially overcome by feeding a diabetes-protective diet.通过喂食糖尿病保护饮食,部分克服了LEW.1AR1-iddm大鼠的肠道免疫缺陷。
Immunology. 2015 Jul;145(3):417-28. doi: 10.1111/imm.12457. Epub 2015 Mar 29.
8
Gut microbial markers are associated with diabetes onset, regulatory imbalance, and IFN-γ level in NOD mice.肠道微生物标志物与非肥胖糖尿病(NOD)小鼠的糖尿病发病、调节失衡及γ干扰素水平相关。
Gut Microbes. 2015;6(2):101-9. doi: 10.1080/19490976.2015.1011876. Epub 2015 Feb 3.
9
Innate and adaptive type 2 immune cell responses in genetically controlled resistance to intestinal helminth infection.基因控制的对肠道蠕虫感染抵抗力中的固有和适应性2型免疫细胞反应
Immunol Cell Biol. 2014 May-Jun;92(5):436-48. doi: 10.1038/icb.2013.109. Epub 2014 Feb 4.
10
Autoimmunity in 2012.2012 年的自身免疫。
Clin Rev Allergy Immunol. 2013 Oct;45(2):290-301. doi: 10.1007/s12016-013-8386-7.